Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
GADD45A is a protective modifier of neurogenic skeletal muscle atrophy
Jeffrey T. Ehmsen, Riki Kawaguchi, Damlanur Kaval, Anna E. Johnson, Daniel Nachun, Giovanni Coppola, Ahmet Höke
Jeffrey T. Ehmsen, Riki Kawaguchi, Damlanur Kaval, Anna E. Johnson, Daniel Nachun, Giovanni Coppola, Ahmet Höke
View: Text | PDF
Research Article Muscle biology Neuroscience

GADD45A is a protective modifier of neurogenic skeletal muscle atrophy

  • Text
  • PDF
Abstract

Neurogenic muscle atrophy is the loss of skeletal muscle mass and function that occurs with nerve injury and in denervating diseases, such as amyotrophic lateral sclerosis. Aside from prompt restoration of innervation and exercise where feasible, there are currently no effective strategies for maintaining skeletal muscle mass in the setting of denervation. We conducted a longitudinal analysis of gene expression changes occurring in atrophying skeletal muscle and identified growth arrest and DNA damage-inducible A (Gadd45a) as a gene that shows one of the earliest and most sustained increases in expression in skeletal muscle after denervation. We evaluated the role of this induction using genetic mouse models and found that mice lacking GADD45A showed accelerated and exacerbated neurogenic muscle atrophy, as well as loss of fiber type identity. Our genetic analyses demonstrate that, rather than directly contributing to muscle atrophy as proposed in earlier studies, GADD45A induction likely represents a protective negative feedback response to denervation. Establishing the downstream effectors that mediate this protective effect and the pathways they participate in may yield new opportunities to modify the course of muscle atrophy.

Authors

Jeffrey T. Ehmsen, Riki Kawaguchi, Damlanur Kaval, Anna E. Johnson, Daniel Nachun, Giovanni Coppola, Ahmet Höke

×

Figure 4

Absence of Gadd45a induction in skeletal muscle myocytes results in increased atrophy of multiple fiber types and loss of fiber type identity.

Options: View larger image (or click on image) Download as PowerPoint
Absence of Gadd45a induction in skeletal muscle myocytes results in incr...
Baseline minimum Feret diameters of type I, type IIa, and non–I/IIa myofibers did not differ among WT, heterozygous, Gadd45afl, HSA-Cre:Gadd45afl (muscle-specific Gadd45a deletion), and CMV-Cre:Gadd45afl (ubiquitous Gadd45a deletion) genotypes (A–E, scale bar: 100 μm; K, multiple linear regression, with pairwise comparisons determined by linear combination). Type I, type IIa, and non–I/IIa myofibers from denervated soleus of HSA-Cre:Gadd45afl and CMV-Cre:Gadd45afl mice all showed significantly reduced minimum Feret diameters by 14 days postdenervation compared with all other genotypes (F–J, and L, multiple linear regression, with pairwise comparisons determined by linear combination). The box plots depict the minimum and maximum values (whiskers), the upper and lower quartiles, and the median. The length of the box represents the interquartile range. In addition, denervated soleus from HSA-Cre:Gadd45afl and CMV-Cre:Gadd45afl genotypes showed a significant increase (P < 0.001) in the proportion of non–I/IIa myofibers, with prominent loss of Myh2-expressing fibers (type IIa), suggesting accelerated loss of myofiber identity in the absence of GADD45A expression (M, Pearson’s χ2 test).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts